Nanomedicine Drug Development: A Scientific Symposium Entitled “Charting a Roadmap to Commercialization”
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanomedicine Drug Development: A Scientific Symposium Entitled “Charting a Roadmap to Commercialization”
Authors
Keywords
Active Target, Clinical Trial Design, Mononuclear Phagocyte System, Breakout Session, Preclinical Pharmacology
Journal
AAPS Journal
Volume 16, Issue 4, Pages 698-704
Publisher
American Association of Pharmaceutical Scientists (AAPS)
Online
2014-05-13
DOI
10.1208/s12248-014-9608-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Folate-Targeted Nanoparticle Size on Their Rates of Penetration into Solid Tumors
- (2013) Erina Vlashi et al. ACS Nano
- Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
- (2013) U. Prabhakar et al. CANCER RESEARCH
- A Review of Study Designs and Outcomes of Phase I Clinical Studies of Nanoparticle Agents Compared with Small-Molecule Anticancer Agents
- (2013) W. P. Caron et al. CLINICAL CANCER RESEARCH
- Nanoparticle clearance is governed by Th1/Th2 immunity and strain background
- (2013) Stephen W. Jones et al. JOURNAL OF CLINICAL INVESTIGATION
- Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines
- (2013) Marina A. Dobrovolskaia et al. JOURNAL OF CONTROLLED RELEASE
- Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory
- (2012) Rachael M. Crist et al. Integrative Biology
- PEGylated PRINT Nanoparticles: The Impact of PEG Density on Protein Binding, Macrophage Association, Biodistribution, and Pharmacokinetics
- (2012) Jillian L. Perry et al. NANO LETTERS
- Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft
- (2012) Kevin S. Chu et al. Nanomedicine-Nanotechnology Biology and Medicine
- Mucus-Penetrating Nanoparticles for Vaginal Drug Delivery Protect Against Herpes Simplex Virus
- (2012) L. M. Ensign et al. Science Translational Medicine
- Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial
- (2010) G. P. Stathopoulos et al. ANNALS OF ONCOLOGY
- Improved anti-tumor activity of stabilized anthracycline polymeric micelle formulation, NC-6300
- (2010) Mitsunori Harada et al. CANCER SCIENCE
- Clinical Developments in Nanotechnology for Cancer Therapy
- (2010) Jeremy D. Heidel et al. PHARMACEUTICAL RESEARCH
- Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies
- (2009) Shivaani Kummar et al. JOURNAL OF CLINICAL ONCOLOGY
- Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
- (2008) Frank Alexis et al. MOLECULAR PHARMACEUTICS
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
- Nanotechnology and Cancer
- (2007) James R. Heath et al. Annual Review of Medicine
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started